medigraphic.com
SPANISH

Revista Médica de la Universidad Autónoma de Sinaloa REVMEDUAS

ISSN 2007-8013 (Print)
Órgano oficial de la Universidad Autónoma de Sinaloa
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 4

<< Back Next >>

Rev Med UAS 2022; 12 (4)

Asymptomatic obstructive asymmetric hypertrophic cardiomyopathy in late adolescence

Rosales-Martínez J, Lara-Duck MF, Gutiérrez-Sierra A, Mayek-Pérez N
Full text How to cite this article

Language: English
References: 7
Page: 332-337
PDF size: 244.84 Kb.


Key words:

Genetic hypertrophic cardiomyopathy, mild outflow tract obstruction, calcification and thickening of the mitral valve.

ABSTRACT

An 18-years-old adolescent with asymmetric mid-ventricular hypertrophic cardiomyopathy, undiagnosed because he did not present symptoms. The electrocardiogram indicated an increase in the QT interval, without arrhythmias; the transthoracic echocardiogram revealed asymmetric mid-ventricular hypertrophy, with mild obstruction of the left ventricular outflow tract; the mitral valve was thickened and calcified. Symptoms were not found because the outflow tract obstruction was not noticeable; as hypertrophy increased, the symptoms appeared. The thickening and calcification of the mitral valve, uncommon for the patient's age, could cause mitral regurgitation or heart failure.


REFERENCES

  1. Estigarribia-Passaro J, Vidal-Cortinas I,Báez A, Vidal JL. Miocardiopatía HipertróficaAspectos Conceptuales de la Enfermedady Fundamentos del Registro Uruguayode Miocardiopatía Hipertrófica. Rev UrugCardiol 2011; 26: 27-37.

  2. Nagueh SF, Smiseth OA, Appleton CP,Byrd BF 3rd, Dokainish H, Edvardsen T, etal. Recommendations for the Evaluation ofLeft Ventricular Diastolic Function by Echocardiography:An Update from the AmericanSociety of Echocardiography and the European Association of Cardiovascular Imaging.J Am Soc Echocardiogr 2016; 29: 277-

  3. 314.3. Edelson JB, Griffis H, Burstein DS, ZhangX, Rossano JW, Lin KY, et al. The Impact ofSyndromic Genetic Disorders on MedicalManagement and Mortality in Pediatric HypertrophicCardiomyopathy Patients. PediatrCardiol 2020; 41: 1180-9.

  4. Alashi A, Svensson L, Klein J, Zahka K,Smedira NG, Najm H, et al. Characteristicsand Longer-Term Outcomes of ContemporaryPatients <18 Years of Age with HypertrophicCardiomyopathy. Am J Cardiol2021; 140: 110-17.

  5. Rowin EJ, Sridharan A, Madias C, Firely C,Koethe B, Link MS, et al. Prediction andPrevention of Sudden Death in Young Patients(<20 years) with Hypertrophic Cardiomyopathy.Am J Cardiol 2020; 128: 75-83.

  6. Nishimura RA, Holmes DR. HypertrophicObstructive Cardiomyopathy. N Engl J Med2004; 350: 1320-27.

  7. Geske JB, Ommen SR, Gersh BJ. HypertrophicCardiomyopathy: Clinical Update.JACC Hear Fail 2018; 6: 364-75.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med UAS. 2022;12